GA induces caspase‐3/GSDME‐dependent pyroptosis and inhibits CRC progression.[178] Thus, by triggering pyroptosis, chemotherapeutic agents can modulate TME, thereby enhancing the antitumor ability. The gene discussed is GSDME; the disease is colorectal carcinoma.